Stockscreener 앱 받기
8.96
2.50%
-0.23
시간 외 거래:
8.96
Fennec Pharmaceuticals Inc 주식(FENC)의 최신 뉴스
Fennec Pharmaceuticals : Announces Results of Annual Meeting - marketscreener.com
New Fennec hire gets 10,000 stock options at $9, 10-year term - Stock Titan
FENC News | FENNEC PHARMACEUTICALS INC (NASDAQ:FENC) - ChartMill
Fennec Pharmaceuticals (FENC) Edges Higher as Biotech Sector Sees Mixed ActivitySector ETF Flow - newsline.com
Fennec Shareholders Approve Governance, Compensation and Equity Plans - TipRanks
FENNEC (NASDAQ: FENC) director receives fully vested options for 20,000 shares - Stock Titan
Fennec Pharmaceuticals (NASDAQ: FENC) director granted 20,000 stock options at $8.70 - Stock Titan
FENNEC (FENC) director Khalid Islam receives options on 25,000 shares - Stock Titan
FENNEC (FENC) director Chris Rallis receives fully vested option grant - Stock Titan
Fennec (NASDAQ: FENC) investors back directors, pay and new equity plans - Stock Titan
Fennec Pharmaceuticals (FENC) Faces Modest Pullback: Key Levels to WatchUp Down Volume - newsline.com
Fennec Announces Results of Annual Meeting - The Manila Times
Fennec investors re-elect directors, approve auditor and pay - Stock Titan
Technical Reactions to FENC Trends in Macro Strategies - Stock Traders Daily
Why Fennec Pharmaceuticals Inc stock is sliding today - Wealth Awesome
Insider Favorites High Growth Companies June 2026 - simplywall.st
ASCO 2026 drives scientific collaboration for Fennec Pharmaceuticals in hearing loss prevention research - Traders Union
Fennec Pharmaceuticals (NASDAQ: FENC) director exercises options, sells shares for tax obligations - Stock Titan
Insider sale notice: Rostislav Raykov to sell 9,747 shares (FENC) - Stock Titan
Fennec Pharmaceuticals (FENC) CSO gains 156 vested shares in Form 4 filing - Stock Titan
Fennec Pharmaceuticals (FENC) CCO awarded 168 common shares in Form 4 - Stock Titan
Fennec Pharmaceuticals (FENC) CMO receives 168-share grant, holds 21,015 - Stock Titan
Fennec Pharmaceuticals (FENC) CEO receives 1,159-share stock award - Stock Titan
Fennec (NASDAQ: FENC) CFO gains 1,703 shares as prior awards vest - Stock Titan
Trading the Move, Not the Narrative: (FENC) Edition - Stock Traders Daily
Fennec Pharmaceuticals targets cisplatin-induced hearing loss with new survivorship research at ASCO26 - Traders Union
Fennec Pharmaceuticals Inc.Common Stock (NQ: FENC - FinancialContent
Fennec Pharmaceuticals (FENC) Gains 1.7% as Shares Bounce Off Support — Key Levels in FocusStandard Deviation - The Legal Advocate
Fennec Pharmaceuticals Drives PEDMARK Sales as Q1 Revenue Hits Peak - HarianBasis.co
Adherex Technologies’ PEDMARK Push Targets Larger AYA Market After Record Quarter - Yahoo Finance
H.C. Wainwright raises Fennec Pharmaceuticals stock price target on growing adoption By Investing.com - Investing.com Australia
Fennec Showcases New PEDMARK Data at ASCO 2026 - TipRanks
New PEDMARK studies at 2026 ASCO showcased by Fennec (NASDAQ: FENC) - Stock Titan
Maxim Group Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating, Maintains Target Price $15 - Moomoo
H.C. Wainwright raises Fennec Pharmaceuticals stock price target on growing adoption - Investing.com Nigeria
symbol__ Stock Quote Price and Forecast - CNN
Fennec Announces New Research Supporting Pedmark's Use at ASCO Annual Meeting - Moomoo
H.C. Wainwright Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating, Raises Target Price to $16 - Moomoo
Fennec Pharmaceuticals Announced New Research Supporting Integration and Use of PEDMARK at 2026 ASCO Annual Meeting - Moomoo
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting - The Manila Times
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of Pedmark - marketscreener.com
New cancer studies test PEDMARK to protect patients’ hearing - Stock Titan
(FENC) Volatility Zones as Tactical Triggers - Stock Traders Daily
Fennec Pharmaceuticals Grants Inducement Stock Options to New Employees Under Nasdaq Rule and Highlights PEDMARK®/PEDMARQSI® Commercialization Progress 1 - Minichart
(FRX) Strategic Market Analysis (FRX:CA) - Stock Traders Daily
Fennec (NASDAQ: FENC) issues 50,000 inducement stock options to new hires - Stock Titan
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Fennec Pharmaceuticals : Corporate Presentation May 2026 - marketscreener.com
Three new Fennec hires get options on 50,000 shares at $9.75 - Stock Titan
Fennec Pharmaceuticals Inc Company Profile & Introduction - Moomoo
Fennec Pharmaceuticals(FENC) Stock Options Chain | Quotes & News - Moomoo
Fennec Pharmaceuticals shares rise after earnings and revenue beat forecasts (FENC) - MSN
Fennec Pharmaceuticals (FENC) Stock Forum and Discussion - Moomoo
[SCHEDULE 13G/A] FENNEC PHARMACEUTICALS INC. Amended Passive Investment Disclosure - Stock Titan
Piper Sandler Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating, Maintains Target Price $18 - Moomoo
Fennec Pharmaceuticals (NASDAQ:FENC) Is In A Strong Position To Grow Its Business - Moomoo
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q1 2026 Earnings Call Transcript - Insider Monkey
Fennec Pharmaceuticals Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
1.27%
1.43%
자본화:
|
볼륨(24시간):